Colorectal cancer diagnoses and deaths surge among adults under 50, yet screening rates for those newly eligible at ages 45-49 remain alarmingly low at just 22.5%, leaving families vulnerable to preventable tragedy.
Story Highlights
- Only 22.5% of adults aged 45-49 completed screening in 2022, up slightly from 19.7% in 2021 despite guideline changes.
- Rising CRC incidence and deaths in under-50s, with rectal cancer up 1% annually, and half of cases in the 45-49 group are often advanced stage.
- No clear link to social needs, such as food or housing insecurity, after adjustments, suggesting other unknown barriers.
- U.S. overall screening at 59%, far below 80% goal, with the lowest rates among uninsured, low-education, and rural populations.
- Experts call for awareness campaigns and policy action to boost uptake and save lives.
Rising Threat of Early-Onset Colorectal Cancer
Colorectal cancer incidence in adults under 50 increased steadily since the mid-2000s, with rectal cancer rising 1% annually and deaths climbing 1% yearly.
The American Cancer Society lowered the screening age to 45 in 2018, followed by the USPSTF adoption in 2021. Despite evidence of precancerous polyps and cancers in 45-49 year-olds matching 50-54 year-olds, uptake lags.
Historical declines in overall rates reversed post-2000s due to obesity, sedentary lifestyles, alcohol, ultraprocessed foods, and environmental factors. This trend burdens families seeking personal responsibility for health.
Low Screening Uptake Persists Post-Guideline Change
UCLA researchers analyzed 2022 BRFSS data from 13,300 adults aged 45-49, finding that 22.5% completed screening, up from 19.7% in 2021. Among screened, 61% used colonoscopy and 32% stool-based tests. Rates remain at 20-37% as of 2026, far below those of older adults and the national average of 59%.
Disparities hit uninsured at 21%, low-education groups, Asian Americans, and non-metro areas hardest. Kaiser Permanente data from 2021-2024 colonoscopies confirmed yields in 45-49% of cases, matching older groups, validating guidelines. Half of under-50 diagnoses occur in this eligible cohort.
Colorectal cancer is rising in adults under 50, yet too few people in this age group get screened in time to catch it early. https://t.co/Ons3QeatnF
— ABC News (@ABC) March 2, 2026
Unclear Barriers Demand Action
The UCLA study found no association between screening and unmet social needs, such as food, housing, or transport insecurity, after adjustments. Prior data suggested sociodemographic factors, but controls eliminated this association.
Dr. Katherine Chen urges media campaigns and policies to improve access. A UCLA randomized trial tests outreach that offers FIT or colonoscopy options versus usual care.
ACS 2026 report notes 37% prevalence in 45-49 but persistent rises in diagnoses and deaths. Limited data on family history and self-report bias highlight research gaps.
Impacts on Families and Economy
Low screening results in three-quarters of under-50 CRC cases diagnosed at advanced stages, dropping 5-year survival below 95% for localized disease.
Short-term missed detections account for 50% of under-50 cases in the 45-49 group. Long-term, 1% annual death increases strain communities, especially low-SES families.
Advanced treatments raise costs and widen disparities. NCCRT pushes for 80% screening via multimodal options. Endoscopy demand surges 10-fold post-guidelines, stressing systems. Stakeholders such as the USPSTF, ACS, and researchers drive standards and interventions.
Sources:
Colorectal cancer screening lags adults 45-49 diagnosis
Population Health Colorectal Cancer Screening Strategies Adults Aged 45-49 Years Randomized Clinical
Exact Sciences Colorectal Cancer Screening Adherence Screening Rates
ACS Pressroom Rectal Cancer Incidence Rising
Kaiser Permanente Support Colon Cancer Screen 45
JNCI Advance Article UCLA Study
NCCRT Our Impact Data and Progress
JAMA Network Open Full Article
